GCM
ABBV icon

Generation Capital Management’s AbbVie ABBV Stock Holding History

Generation Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$398K Sell
1,830
-2
-0.1% -$444 0.29% 57
2025
Q4 		$419K Buy
1,832
+2
+0.1% +$456 0.27% 63
2025
Q3 		$424K Hold
1,830
– – 0.31% 60
2025
Q2 		$340K Buy
1,830
+115
+7% +$21.4K 0.27% 62
2025
Q1 		$359K Sell
1,715
-160
-9% -$31.1K 0.32% 55
2024
Q4 		$333K Buy
+1,875
New +$345K 0.29% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Generation Capital Management's ABBV Position: Q1 2026 in Review

Generation Capital Management reduced its AbbVie (ABBV) stake by 0.11% in Q1 2026, selling an estimated $444 and leaving 1,830 shares worth $398K. The position accounts for 0.29% of the portfolio, ranked #57.

Generation Capital Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $424K in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Generation Capital Management held 1,830 shares of AbbVie worth $398K as of Q1 2026.
  • Generation Capital Management sold 2 AbbVie shares in Q1 2026, an estimated $444.
  • AbbVie made up 0.29% of Generation Capital Management's portfolio in Q1 2026, its #57 holding.
  • Generation Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Generation Capital Management's AbbVie position peaked at $424K in Q3 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Generation Capital Management's 13F filing for Q1 2026, filed 8 May 2026.